Correlation Between AptaBio Therapeutics and Hanwha Life

Can any of the company-specific risk be diversified away by investing in both AptaBio Therapeutics and Hanwha Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AptaBio Therapeutics and Hanwha Life into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between AptaBio Therapeutics and Hanwha Life Insurance, you can compare the effects of market volatilities on AptaBio Therapeutics and Hanwha Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AptaBio Therapeutics with a short position of Hanwha Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of AptaBio Therapeutics and Hanwha Life.

Diversification Opportunities for AptaBio Therapeutics and Hanwha Life

0.84

Correlation Coefficient

AptaBio Therapeutics  Hanwha Life

Very poor diversification

The 3 months correlation between AptaBio and Hanwha is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding AptaBio Therapeutics and Hanwha Life Insurance in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hanwha Life Insurance and AptaBio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AptaBio Therapeutics are associated (or correlated) with Hanwha Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hanwha Life Insurance has no effect on the direction of AptaBio Therapeutics i.e., AptaBio Therapeutics and Hanwha Life go up and down completely randomly.

Pair Corralation between AptaBio Therapeutics and Hanwha Life

Assuming the 90 days trading horizon AptaBio Therapeutics is expected to generate 1.56 times more return on investment than Hanwha Life. However, AptaBio Therapeutics is 1.56 times more volatile than Hanwha Life Insurance. It trades about -0.1 of its potential returns per unit of risk. Hanwha Life Insurance is currently generating about -0.16 per unit of risk. If you would invest  780,000  in AptaBio Therapeutics on October 6, 2024 and sell it today you would lose (115,000) from holding AptaBio Therapeutics or give up 14.74% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

AptaBio Therapeutics  vs.  Hanwha Life Insurance

AptaBio Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AptaBio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Hanwha Life Insurance

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Hanwha Life Insurance has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with AptaBio Therapeutics and Hanwha Life

The main advantage of trading using opposite AptaBio Therapeutics and Hanwha Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AptaBio Therapeutics position performs unexpectedly, Hanwha Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hanwha Life will offset losses from the drop in Hanwha Life's long position.

The idea behind AptaBio Therapeutics and Hanwha Life Insurance pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..